On August 8, Temple University School of Medicine welcomed the Class of 2018 to the profession of medicine with a White Coat Ceremony, an event held at the start of every school year to welcome each new class to the Temple family and the medical profession. Proud family members snapped photos and broke into rounds of applause as the students were cloaked, by members of the School’s faculty, in the crisp white coats they will wear throughout all four years of their education.
Seneca Harberger, a medical student at Temple University School of Medicine, has been named a 2014 Pisacano Scholar by the Board of Directors of the Pisacano Leadership Foundation, Inc., of the American Board of Family Medicine.
Temple University Hospital is the first hospital in the Philadelphia region to offer an innovative, minimally-invasive technology that improves long-term outcomes for patients with complex anatomies undergoing endovascular repair of abdominal aortic aneurysms (EVAR). The Aorfix™ Endovascular Stent Graft utilizes a flexible, helical and circular design to conform to the natural contours of human anatomy, including highly-angled aortic necks.
Temple University Hospital has performed the Philadelphia region's first surgery using the new da Vinci® Xi™ Surgical System. Surgeons at Temple successfully performed a minimally invasive robotic mitral valve repair using the da Vinci Xi on July 22. The new technology has broader capabilities than prior generations of surgical robots.
Temple University Hospital is the first hospital in Pennsylvania to offer an innovative procedure that improves long-term outcomes for patients undergoing endovascular repair of thoracic aortic aneurysms (TEVAR). Using a spiral-shaped screw which is delivered from inside the aorta, the Heli-FX™ Thoracic EndoAnchor System uses a special anchor technology to secure stents to the wall of the aorta, preventing migration of the stent and providing a leak-resistant seal between the stent and the aorta.
Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by Gil Yosipovitch, MD, Chairman of the Department of Dermatology at Temple University School of Medicine.
Cherie P. Erkmen, MD, has been appointed Director of the Lung Cancer Screening Program at Temple University Hospital, and Associate Professor of Surgery at Temple University School of Medicine, effective July 21, 2014.
Patients who have a clot in their legs and are considering whether to be treated with traditional blood-thinning medication or undergo a minimally-invasive catheter-based clot removal procedure should feel comfortable that there is no difference in death rates between the two treatments, although there are more bleeding risks with the catheter procedure, according to a study by Temple University School of Medicine researchers. The study involved a review of more than 90,000 cases nationwide.